Table 3.
Sample | Median sFas (pg/ml) (IQR) | Median sFasL (pg/ml) (IQR) | |
---|---|---|---|
Serum | CL | 4818 (1316) | 128 (46) |
Control | 5728 (2192) | 90 (43) |
Serum levels of sFas and sFasL remain normal during CL (controls, n = 15; CL = 19).
Sample | Median sFas (pg/ml) (IQR) | Median sFasL (pg/ml) (IQR) | |
---|---|---|---|
Serum | CL | 4818 (1316) | 128 (46) |
Control | 5728 (2192) | 90 (43) |
Serum levels of sFas and sFasL remain normal during CL (controls, n = 15; CL = 19).